Matches in Wikidata for { <http://www.wikidata.org/entity/Q104130182> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q104130182 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 8ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104130182 description "article scientifique publié en 2020" @default.
- Q104130182 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104130182 description "scientific article published on 08 December 2020" @default.
- Q104130182 description "wetenschappelijk artikel" @default.
- Q104130182 description "наукова стаття, опублікована 8 грудня 2020" @default.
- Q104130182 name "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 name "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 name "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 type Item @default.
- Q104130182 label "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 label "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 label "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 prefLabel "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 prefLabel "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 prefLabel "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 P1433 Q104130182-E6FF3FA7-1AA4-458D-AB10-6E72740988B4 @default.
- Q104130182 P1476 Q104130182-FE5E3D77-9469-4DCF-9058-18604648487D @default.
- Q104130182 P2093 Q104130182-15CBE5C4-8E94-4450-8CE6-DCED9A634F53 @default.
- Q104130182 P31 Q104130182-9AEEDBAA-92AC-4FF1-969B-3D4BF101F973 @default.
- Q104130182 P356 Q104130182-543F579B-CB04-4CCE-A34D-3C293BD4B546 @default.
- Q104130182 P50 Q104130182-377282F9-AA40-41FE-A6EB-593B60CFEA54 @default.
- Q104130182 P577 Q104130182-BAEBCB42-DC1E-4427-9D90-4A3702044219 @default.
- Q104130182 P698 Q104130182-A51A86CC-9118-4D97-A44A-8556D0A7EBD0 @default.
- Q104130182 P921 Q104130182-3459B5C5-6882-4305-8548-86ED30E1DEA1 @default.
- Q104130182 P356 FCP.12637 @default.
- Q104130182 P698 33290594 @default.
- Q104130182 P1433 Q15760364 @default.
- Q104130182 P1476 "Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study" @default.
- Q104130182 P2093 "Joachim Alexandre" @default.
- Q104130182 P31 Q13442814 @default.
- Q104130182 P356 "10.1111/FCP.12637" @default.
- Q104130182 P50 Q89692501 @default.
- Q104130182 P577 "2020-12-08T00:00:00Z" @default.
- Q104130182 P698 "33290594" @default.
- Q104130182 P921 Q84263196 @default.